8th Eurasian Hematology Oncology Summit
2021 Efficacy Data Review in Relapsed CLL: BTK Inhibitors, Ven+/-Rituximab, LOXO-305
By
8th Eurasian Hematology Oncology Summit
FEATURING
Susan O'Brien
By
8th Eurasian Hematology Oncology Summit
FEATURING
Susan O'Brien
Login to view comments.
Click here to Login